Are You At Risk for Dementia? New Blood Test May Tell
By Dennis Thompson HealthDay Reporter
THURSDAY, Dec. 19, 2024 -- Folks worried that they’re developing dementia have few options for catching their brain decline before it's too late.
But a new blood test might be able to detect early changes that wind up leading to cognitive impairment and dementia.
The test looks at a protein that appears to play a role in the ability of drugs, nutrients, water and other substances to pass through the walls of a blood vessel.
Higher levels of this protein -- placental growth factor (PlGF) – could be a warning sign for a possible decline in brain function, researchers reported Dec. 18 in the journal Alzheimer’s & Dementia.
“PlGF could be used as a cost-effective screening tool for identifying patients at risk for vascular brain injury before the insidious onset of cognitive decline,” lead researcher Dr. Kyle Kern, a vascular neurologist at UCLA Health, said in a university news release.
“As a simple blood test, such a tool would be valuable not only for patients and clinicians, but also for researchers identifying patients for clinical trials,” Kern added.
Leaky blood vessels that allow fluid and inflammatory biochemicals to seep into brain tissue have been increasingly recognized as a key driver of cognitive decline and dementia, researchers said in background notes.
Unfortunately, this brain health problem is currently diagnosed using MRI scans, which tend to catch it after the damage has been done, researchers added.
For this study, researchers analyzed blood samples and MRI scans from 370 seniors with an average age of 72.
Results showed that higher PIGF levels were associated with more water in the brain, and more changes in white matter that have been associated with increased brain aging.
Evidence also suggests that people with these brain changes scored lower on cognitive testing.
Early detection of brain changes related to dementia could allow doctors to develop or apply treatments that could protect brain health, researchers said.
“Ideally, PlGF could be used to screen younger populations for whom currently available treatments and lifestyle modifications may prevent or reverse the deleterious effects of vascular injury before the onset of cognitive dysfunction,” researchers noted.
However, they added that more research is needed to make sure PIGF is a solid means of predicting dementia.
Sources
- UCLA, news release, Dec. 18, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Recalled: More Than 67,000 Cases of Deodorant Sold at Dollar Tree, Walmart, and Amazon
TUESDAY, July 22, 2025 — More than 67,000 cases of Power Stick deodorant have been recalled due to an undisclosed manufacturing issue. The recalled deodorants, made by A.P...
Dogs Can Sniff Out Parkinson's Disease, Study Shows
TUESDAY, July 22, 2025 — Dogs’ noses are sensitive enough to track down fleeing convicts, locate human remains in hidden burial sites and detect illicit drug...
For Some, Gluten Intolerance Is Psychological, Study Says
TUESDAY, July 22, 2025 — Gluten intolerance might be all in the minds of some people with irritable bowel syndrome (IBS), results from a small-scale experiment...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.